bioRxiv/medRxiv TRiP Review Activity

279 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 27: Articles 261-270  | Next

RNF43 inhibits WNT5A driven signaling and suppresses melanoma invasion
Radaszkiewicz, T., Noskova, M., Gömöryova, K., Vondalova Blanarova, O., Radaszkiewicz, K. A., Pickova, M., Vichova, R., Gybel, T., Kaiser, K., Demkova, L., Kucerova, L., Potesil, D., Zdrahal, Z., Soucek, K., Bryja, V.
10.1101/2021.02.08.430210 — Posted: 2021-02-10 — Discussion: 2021-02-11  eLife
Loss of MGA mediated Polycomb repression promotes tumor progression and invasiveness
Mathsyaraja, H., Catchpole, J., Eastwood, E., Babaeva, E., Geuenich, M. J., Cheng, P.-F., Freie, B., Ayers, J. L., Yu, M., Wu, N., Poudel, K. R., Koehne, A., Grady, W., Houghton, A. M., Shiio, Y., MacPherson, D. P., Eisenman, R. N.
10.1101/2020.10.16.334714 — Posted: 2020-10-17 — Discussion: 2021-01-27  eLife
Intravital Deep-Tumor Single-Beam 2-, 3- and 4-Photon Microscopy
Bakker, G.-J., Weischer, S., Heidelin, J., Andresen, V., Beutler, M., Friedl, P.
10.1101/2020.09.29.312827 — Posted: 2020-09-30 — Discussion: 2020-12-23  eLife
Gene expression has more power for predicting in vitro cancer cell vulnerabilities than genomics
Dempster, J. M., Krill-Burger, J., Warren, A., McFarland, J., Golub, T., Tsherniak, A.
10.1101/2020.02.21.959627 — Posted: 2020-02-24 — Discussion: 2020-12-15  eLife
Discovering biomarkers of chemotherapy resistance using in vitro evolution in haploid human cells
Jado, J. C., Dow, M., Fonseca, G., Carolino, K., Ideker, T., Carter, H., Winzeler, E.
10.1101/2020.03.17.982181 — Posted: 2020-03-18 — Discussion: 2020-11-19  eLife
Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the immunoreceptor CD300a
Nakahashi-Oda, C., Shibuya, A., Nakazawa, Y., Kanemaru, K.
10.1101/2020.11.10.376715 — Posted: 2020-11-10 — Discussion: 2020-11-12  eLife
Phenotypic plasticity and partial EMT underlie local invasion and distant metastasis in colon cancer
Sacchetti, A., Teeuwssen, M., Verhagen, M., Joosten, R., Gusinac, A., Watson, M. M., Stabile, R., Kim, W. K., Ubink, I., van de Werken, H. J., Fumagalli, A., Paauwe, M., van Rheenen, J., Sansom, O. J., Kranenburg, O., Fodde, R.
10.1101/2020.07.24.219238 — Posted: 2020-07-24 — Discussion: 2020-10-26  eLife
The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma
Polaski, J. T., Udy, D. B., Escobar-Hoyos, L. F., Askan, G., Leach, S. D., Ventura, A., Kannan, R., Bradley, R. K.
10.1101/2020.08.14.248864 — Posted: 2020-08-14 — Discussion: 2020-10-22  eLife
A statistical framework for assessing pharmacological response and biomarkers with confidence
Wang, D., Hensman, J., Kukaite, G., Toh, T. S., GDSC Screening Team, , Dry, J. R., Saez-Rodriguez, J., Garnett, M., Menden, M. P., Dondelinger, F.
10.1101/2020.05.01.072983 — Posted: 2020-05-03 — Discussion: 2020-10-05  eLife
CBX2 and CBX7 antagonistically regulate metabolic reprogramming in breast cancer
Iqbal, M. A., Siddiqui, S., Ur Rehman, A., Siddiqui, F. A., Singh, P., Kumar, B., Saluja, D.
10.1101/2020.08.06.239129 — Posted: 2020-08-06 — Discussion: 2020-09-30  eLife

Evaluation Sources